News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Week In Review: Columbia China Building $150 Million Hospital In Jiaxing



8/28/2017 9:22:10 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
Deals and Financings

- Columbia China, a JV formed by Seattle's Columbia Pacific and Temasek from Singapore, is building a $150 million 500-bed multi-specialty hospital in Jiaxing, Zhejiang Province;

- Fosun Pharma may scale back its $1.3 billion, 86% acquisition of India's Gland Pharma to a 74% transaction that will circumvent an expected rejection from India's regulators;

- Samsung Bioepis of South Korea announced a joint venture with Japan's Takeda Pharma to develop novel biologic drugs, starting with a pancreatitis treatment;

- HitGen of Chengdu and Houston will use its platform to discover drugs in a partnership with Aduro Biotech, a California immunocology company;

- Zhejiang Hisun Pharma will provide scale-up services for a novel inhaled drug resistant TB treatment developed by Seattle's Infectious Disease Research Institute;

- Eone-Diagnomics Genome Center Co. of South Korea will form a JV with GPBio of China to expand Asian markets for their consumer and genetic analysis services;

- GlaxoSmithKline China will partner with Ali Health to promote Cervarix, GSK's HPV/cervical cancer vaccine in China.

Read at BioSpace.com


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES